IsoPlexis

Public

Branford, ConnecticutBiotechwww.isoplexis.com

IsoPlexis is now publicly traded

The data on this page reflects IsoPlexis's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Oct 7, 2021

Last Round

M&A

Dec 21, 2022

Est. Valuation at Exit

$57.8M

Total Funding Raised

$377.55M

Company Overview

IsoPlexis (NAS: ISO) is a biotechnology company that develops a single-cell detection system to enhance understanding of functional protein biology and cellular signaling networks, thereby accelerating the advancement of innovative cancer therapies.

Sector

Biotech

AI Layer

Application

Keywords

single-cell functional proteomics platformautomated proteomics instrumentsingle-cell functional proteomics consumablesfunctional immune response profilingcellular heterogeneity analysis toolscell therapy development toolsimmuno-oncology research toolsbiomarker discovery platformsingle-cell cytokine secretion analysisproteomics data analysis and visualization suitelow-volume bulk proteomics consumableslife science instrument and consumable sales

IsoPlexis Comparables

Compare IsoPlexis with similar companies based on industry and business-model similarity.

IsoPlexis comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Mabtech AB	65%
Syncell	61%

View all Comparables

IsoPlexis Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Dec 21, 2022
IPO	Oct 7, 2021
Debt	Jan 7, 2021
Series D	Jan 7, 2021
Series C Extension	Jan 9, 2020
Series C	May 14, 2019

View all Funding Rounds

IsoPlexis Investors

Notable investors and investment history

IsoPlexis investors
Investor	Rounds
Evercore ISI	IPO
Connecticut Innovations	Series B, Series C, Series A, Series C Extension
Perceptive Advisors	Debt, Series D
Ally Bridge Group	Debt, Series D
Northpond Ventures	Series C
Morgan Stanley	IPO
Danaher	Debt

View all Investors

IsoPlexis Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

IsoPlexis Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersBranford, Connecticut

Employee Range41

Year Founded2012

Last FundingDec 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.